AU2221497A - Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine - Google Patents

Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine

Info

Publication number
AU2221497A
AU2221497A AU22214/97A AU2221497A AU2221497A AU 2221497 A AU2221497 A AU 2221497A AU 22214/97 A AU22214/97 A AU 22214/97A AU 2221497 A AU2221497 A AU 2221497A AU 2221497 A AU2221497 A AU 2221497A
Authority
AU
Australia
Prior art keywords
felodipine
angina
disorders
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22214/97A
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU2221497A publication Critical patent/AU2221497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU22214/97A 1991-12-02 1997-05-16 Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine Abandoned AU2221497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80131691A 1991-12-02 1991-12-02
US801316 1991-12-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU32454/93A Division AU3245493A (en) 1991-12-02 1992-12-01 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU10169/00A Division AU1016900A (en) 1991-12-02 2000-01-10 Methods and compositions for treating hypertension, angina, and other disorders using optically pures(-) felodipine

Publications (1)

Publication Number Publication Date
AU2221497A true AU2221497A (en) 1997-07-31

Family

ID=25180776

Family Applications (2)

Application Number Title Priority Date Filing Date
AU32454/93A Abandoned AU3245493A (en) 1991-12-02 1992-12-01 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
AU22214/97A Abandoned AU2221497A (en) 1991-12-02 1997-05-16 Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU32454/93A Abandoned AU3245493A (en) 1991-12-02 1992-12-01 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine

Country Status (5)

Country Link
EP (1) EP0661971A1 (en)
JP (1) JPH07501551A (en)
AU (2) AU3245493A (en)
CA (1) CA2125149A1 (en)
WO (1) WO1993010781A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501773D0 (en) * 1995-05-15 1995-05-15 Astra Ab New use
US7018649B2 (en) 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
PT1328273E (en) * 2000-10-23 2008-09-23 Euro Celtique Sa Felodipine transdermal device and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE429652B (en) * 1978-06-30 1983-09-19 Haessle Ab 2,6-dimethyl-4- (2,3-dichlorophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl 5-ethyl ester
EP0353238A1 (en) * 1987-03-27 1990-02-07 Byk Gulden Lomberg Chemische Fabrik Gmbh New intermediate products and process
IT1230752B (en) * 1989-02-17 1991-10-29 Boehringer Biochemia Srl PROCESS FOR THE PREPARATION OF 1,4 POLY-SUBSTITUTED DIHYDROPYRIDINS IN AN ANTIOMERICALLY PURE FORM.

Also Published As

Publication number Publication date
EP0661971A1 (en) 1995-07-12
EP0661971A4 (en) 1995-02-09
AU3245493A (en) 1993-06-28
JPH07501551A (en) 1995-02-16
WO1993010781A1 (en) 1993-06-10
CA2125149A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
AU2221597A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU5311296A (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
AU6194094A (en) Sweetener, process for the preparation thereof and the use thereof
AU7039896A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU2287495A (en) Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine
AU3593393A (en) Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and D(-) and L(+)-substituted 3,3-diphenylalanines and derivatives thereof
EP0647134A4 (en) Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine.
AU7334698A (en) Process for preparing pure flupirtin maleate and its modification
AU1849997A (en) N:1 transcoder
HUP0100640A3 (en) Process for the preparation of 1,4-dihydropyridines
AU3245593A (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
AU5631096A (en) Antihistamine-wound healing compositions and methods for pre paring and using same
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
AU2221497A (en) Methods and compositions for treating hypertension, angina, and other disorders using optically pure S(-) felodipine
AU6993998A (en) Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton
AU4344796A (en) Strongly clampable interdental wedge
AU5639694A (en) 6,7-dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound
AU2002301474A1 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
EP0663822A4 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine.
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
AU6074798A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure S(-) nitrendipine
AU5088690A (en) Keratoconjunctivitis cytotoxin and methods for its use and production
AU1658992A (en) Methods and compositions for treating pulmonary disorders using optically pure terbutaline
EP0794173A3 (en) Polyglycerine ester sulphosuccinates, method for their preparation and their use

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted